4.3 Article

CD25 regulatory T cells determine secondary but not primary remission in EAE:: Impact on long-term disease progression

期刊

JOURNAL OF NEUROIMMUNOLOGY
卷 172, 期 1-2, 页码 73-84

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jneuroim.2005.11.003

关键词

autoimmunity; EAE; CTLA-4; remission; secondary progressive chronicity

向作者/读者索取更多资源

Multiple sclerosis (MS) is often characterized by several relapses and remissions during long-term disease, but neither the responsible cells nor the mechanisms are known to date. Using an animal model of multiple sclerosis, relapsing experimental autoimmune encephalomyelitis (R-EAE) CD4(+)CD25(+) T-reg Cells expressing Foxp3 and CTLA-4 intracellularly and T lymphocytes expressing surface CTLA-4 were identified in the CNS. The first remission occurred even after depletion of T-reg cells, but secondary remissions from EAE were ablated. Despite the unaltered first remission autoantigen rechallenge revealed already an amplified cytokine response during acute phase. These results indicate that the cellular composition during first attack of MS predicts long-term disease progression. (C) 2005 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据